Wayne Pisano
Chairman at ONCOLYTICS BIOTECH INC.
Net worth: 489 443 $ as of 2024-03-30
Profile
Wayne F.
Pisano is currently serving as the Chairman at Oncolytics Biotech, Inc. since 2016.
He is also a Director at Chattem, Inc., a Director at River Acquisition Corp.
since 2010, an Independent Director at Altimmune, Inc. since 2018, and the President of Pirus Biological & Vaccine Consulting.
Previously, Mr. Pisano held the positions of President, Chief Executive Officer & Director at VaxInnate Corp.
from 2012 to 2016, President & Chief Executive Officer at Sanofi Pasteur from 2009 to 2011, Chairman at Provention Bio, Inc. from 2019 to 2023, Independent Director at IMV, Inc. from 2011 to 2021, Director at Aeras Global TB Vaccine Foundation from 2011 to 2019, Senior Vice President-Vaccines at Sanofi, and Vice President at Novartis Pharmaceuticals Corp.Mr. Pisano obtained an MBA from the University of Dayton in 1984 and completed his undergraduate studies at St. John Fisher College in 1976.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC.
0.50% | 2024-03-06 | 380,126 ( 0.50% ) | 402 934 $ | 2024-03-30 |
ALTIMMUNE, INC.
0.02% | 2023-09-27 | 8,498 ( 0.02% ) | 86 510 $ | 2024-03-30 |
Wayne Pisano active positions
| Companies | Position | Start |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Chairman | - |
| ALTIMMUNE, INC. | Director/Board Member | 2018-08-29 |
Chattem, Inc.
 Chattem, Inc. Pharmaceuticals: MajorHealth Technology Chattem, Inc. engages in the manufacture of over-the-counter health and beauty care products. It makes anti-dandruff shampoos, medicated skin care, topical pain care, oral care and internal over-the-counter products. The firm distributes its products to mass merchandisers, drugstores and food retail channels. The company was founded by Zeboim Cartter Patten on February 21, 1879 and is headquartered in Bridgewater, NJ. | Director/Board Member | 2010-03-16 |
River Acquisition Corp.
 River Acquisition Corp. MiscellaneousMiscellaneous River Acquisition Corp. is an investment and acquisition company. The private company is based in San Diego, CA and has subsidiaries in the United States. Gregory Irace has been the CEO of the company since 2010. | Director/Board Member | 2010-03-16 |
| Pirus Biological & Vaccine Consulting | President | - |
Former positions of Wayne Pisano
| Companies | Position | End |
|---|---|---|
| PROVENTION BIO, INC. | Chairman | 2023-04-26 |
| IMV INC. | Director/Board Member | 2021-03-31 |
Aeras Global TB Vaccine Foundation
 Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Director/Board Member | 2019-05-31 |
VaxInnate Corp.
 VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Chief Executive Officer | 2016-10-31 |
| ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Wayne Pisano
| University of Dayton | Masters Business Admin |
| St. John Fisher College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 4 |
|---|---|
| ONCOLYTICS BIOTECH INC. | Health Technology |
| SANOFI | Health Technology |
| IMV INC. | Health Technology |
| ALTIMMUNE, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Chattem, Inc.
Chattem, Inc. Pharmaceuticals: MajorHealth Technology Chattem, Inc. engages in the manufacture of over-the-counter health and beauty care products. It makes anti-dandruff shampoos, medicated skin care, topical pain care, oral care and internal over-the-counter products. The firm distributes its products to mass merchandisers, drugstores and food retail channels. The company was founded by Zeboim Cartter Patten on February 21, 1879 and is headquartered in Bridgewater, NJ. | Health Technology |
Aeras Global TB Vaccine Foundation
Aeras Global TB Vaccine Foundation Miscellaneous Commercial ServicesCommercial Services Aeras Global TB Vaccine Foundation is a non-profit organization, which engages in the development of tuberculosis vaccines in partnership with other biotech, pharmaceutical, and academic organizations. Its product pipeline includes AdS Ag85A, MTBCAV, VPM 1002, and RUTI. The company is headquartered in Rockville, MD. | Commercial Services |
River Acquisition Corp.
River Acquisition Corp. MiscellaneousMiscellaneous River Acquisition Corp. is an investment and acquisition company. The private company is based in San Diego, CA and has subsidiaries in the United States. Gregory Irace has been the CEO of the company since 2010. | Miscellaneous |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
VaxInnate Corp.
VaxInnate Corp. Pharmaceuticals: MajorHealth Technology VaxInnate Corp. develops novel, proprietary vaccines for infectious diseases. It engages in the development and production of vaccines for pandemic and seasonal influenza diseases. The firm's products include Flagellin.HuHA and flagellin.AvHA, which are fusion proteins linking a potent immune stimulator, the bacterial protein flagellin, with immunoprotective domain of viral hemagglutinin. The company was founded by Ruslan Medzhitov, Michael I. Sherman and Richard Flavell in 2002 and is headquartered in Cranbury, NJ. | Health Technology |
Sanofi Pasteur
 Sanofi Pasteur BiotechnologyHealth Technology Sanofi Pasteur SA develops, manufactures and supplies vaccines. It provides vaccines for bacterial and viral diseases, including diphtheria, typhoid fever, and poliomyelitis. The company was founded in 1990 and is headquartered in Lyon, France. | Health Technology |
| Pirus Biological & Vaccine Consulting | |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
- Stock Market
- Insiders
- Wayne Pisano
